Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03083886 · ClinicalTrials.gov registry record · NA
Spine Pain INtervention to Enhance Care Quality And Reduce Expenditure
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 3,087
- Enrollment target
NCT03083886: Completed NA study, sponsored by Brigham and Women's Hospital.
NCT03083886 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 3,087 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (120% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03083886, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,087 participants
- Enrollment target
Study Summary
Low back and neck pain are among the leading causes of medical visits, lost productivity and disability. There is an urgent need to identify effective and efficient ways of helping subjects with acute spine pain while guiding practitioners towards high-value care. This trial will be a block and cluster-randomized open-label multi-centered pragmatic randomized clinical trial comparing healthcare spending and clinical outcomes for subjects with spine pain of less than three months' duration, in whom there are no red flag signs or symptoms. Subjects will be randomized to one of three treatment strategies: (1) usual primary care provider-led care; (2) usual PCP-led care with spine pain treatment directed by the Identify, Coordinate, and Enhanced decision making (ICE) care model, and (3) usual PCP-led care with spine pain treatment directed by the Individualized Postural Therapy (IPT) care model. Our outcomes of interest will be spine-related healthcare utilization at one year as well as pain and functionality of the study participants.
Primary Outcome
Measured by patient self-report
Interventions
- OTHER Identify, Coordinated, Enhanced (ICE) Decision Making + PCP led care
- OTHER Individualized Postural Therapy (IPT) + PCP led care
- OTHER Usual PCP led care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,087 participants |
| Start Date | 2017-06-05 |
| Est. Completion | 2021-06-30 |
| Phase | NA |
What the finished NCT03083886 record still lists
NCT03083886 is an interventional study that assigns participants to a tested intervention. Its 3,087 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (120% higher).
The record links to 0 conditions, and to 3 interventions - of which Identify, Coordinated, Enhanced (ICE) Decision Making + PCP led care is the first listed.
NCT03083886 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03083886 about?
NCT03083886 is a clinical study titled "Spine Pain INtervention to Enhance Care Quality And Reduce Expenditure". Low back and neck pain are among the leading causes of medical visits, lost productivity and disability. There is an urgent need to identify effective and efficient ways of helping subjects with acute spine pain while guiding practitioners towards high-value care. This trial will be a block and clus...
What is the current status of trial NCT03083886?
This trial is currently completed. It is a NA study. The enrollment target is 3,087 participants. The study started on 2017-06-05. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT03083886?
The interventions under investigation include: Identify, Coordinated, Enhanced (ICE) Decision Making + PCP led care (OTHER), Individualized Postural Therapy (IPT) + PCP led care (OTHER), Usual PCP led care (OTHER).
Who is sponsoring clinical trial NCT03083886?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03083886's enrollment target sits among peer trials
3,087 40th of 2000 higher than 1,961 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05534243 · 3,090 participants · NA
The ED-AWARENESS-2 Trial
- NCT06667700 · 3,082 participants · Phase 3
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
- NCT04722822 · 3,100 participants · NA
The HPV 9-10 Trial: Early Initiation of HPV Vaccination
- NCT05051722 · 3,110 participants
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI